查看購物車
  • Simplified Chinese
  • English
  • Japanese
胎盤市場份額,規模,趨勢,行業分析報告,按類型（豬,馬,羊,其他）,按應用,按地區,按細分市場,預測，2023-2032 年
市場調查報告書
商品編碼
1287675

胎盤市場份額,規模,趨勢,行業分析報告,按類型（豬,馬,羊,其他）,按應用,按地區,按細分市場,預測，2023-2032 年

Placenta Market Share, Size, Trends, Industry Analysis Report, By Type (Porcine, Equine, Ovine, Others); By Application; By Region; Segment Forecast, 2023-2032
出版日期: | 出版商: Polaris Market Research | 英文 116 Pages | 商品交期: 最快1-2個工作天內

價格

根據 Polaris 市場研究的最新研究，到 2032 年，全球胎盤市場預計將達到 2.3601 億美元。 該報告提供了對當前市場動態的詳細見解，並對未來市場增長進行了分析。

推動胎盤市場的主要因素之一是對嫩膚和抗衰老產品的需求不斷增長。 一個多世紀以來，利用胎盤中豐富的干細胞來幫助傷口護理和傷口癒合。 生長因子和抗炎蛋白的有效組合，尤其是在羊膜中，可以幫助身體在生病或受傷時與細胞相互作用。

胎盤細胞的正常功能可以在再生藥物的幫助下恢復。 慢性疾病的有效治療有望通過該領域的快速改進而實現。 例如，根據林一峰在2022年發表的研究論文，從人胎盤中產生的間充質乾細胞是一種新的MSC替代來源，具有許多優點。 為了進一步了解其治療功效和潛在的潛在機制，我們向 HP-MSC 注射了交聯透明質酸水凝膠，以優化其在子宮內的保留。

市場擴張的主要驅動力之一是研發的高投資。 在預測期內，對減輕疾病負擔的有效療法的需求不斷增長，也推動了增長。 例如，Felor Biniazan 於 2022 年進行的一項研究調查了基於胎盤的羊膜上皮細胞對小鼠損傷模型中傷口癒合過程和 TGF 誘導的疤痕形成的影響。

例如，Kirat Chand 於 2022 年發表的一項研究表明，hPD-MSC 療法會導致代謝物和蛋白質水平以及衰老和年輕化的血清生物標誌物發生變化。 令人驚訝的是，hPD-MSC 療法由於維生素 B6 代謝加快而增強了血清素合成。 重複輸注治療後肝臟血清素水平的增加改變了與肝細胞增殖和線粒體生物發生相關的 mRNA 和蛋白質的表達。 接受hPD-MSC治療後血液代謝物的變化可以發現衰老和年輕化的生物標誌物。 血清素也是改善與年齡相關的肝臟衰退的重要治療靶點。

胎盤市場報告亮點

  • 2022 年，Ovine 將主導整個市場並佔據主要銷售額。 對含有胎盤提取物的營養補充劑,藥品和化妝品的需求不斷增長是市場擴張的原因。
  • 2022 年，製藥行業主導市場。 推動市場的關鍵因素是臨床試驗的增加,戰略舉措的增加,慢性病患病率的增加以及醫療保健服務的改善。
  • 2022 年，北美地區的銷售額將最大。 推動市場的關鍵因素包括北美強大的生物技術行業,主要參與者的存在,廣泛的研究和開發以及個性化醫療的推廣。
  • 全球市場參與者包括 Brroklyn Placenta Services,Atlanta Placenta,MiMedx Group,TelaGen,Thimba Li 和 Agri-Labco-Products。

內容

第一章簡介

第 2 章執行摘要

第三章研究方法

第 4 章全球胎盤市場洞察

  • 胎盤市場 - 行業概況
  • 胎盤市場動態
    • 驅動因素和機遇
      • 增加使用可再生能源進行能源生產
      • 燃料電池的需求不斷增長
    • 制約因素和問題
      • 生產成本高
  • 杵分析
  • 胎盤行業的趨勢
  • 價值鏈分析
  • COVID-19 的影響分析

第五章全球胎盤市場，按類型

  • 主要發現
  • 簡介
  • 豬
  • 馬
  • 羊
  • 其他

第 6 章全球胎盤市場，按應用劃分

  • 主要發現
  • 簡介
  • 藥品
  • 化妝品
  • 補充劑
  • 其他

第 7 章：全球胎盤市場（按地區）

  • 主要發現
  • 簡介
    • 2019-2032 年胎盤市場評估（按地區）
  • 胎盤市場 - 北美
    • 北美：按應用劃分的胎盤市場，2019-2032 年
    • 北美：按類型劃分的胎盤市場，2019-2032 年
    • 胎盤市場 - 美國
    • 胎盤市場 - 加拿大
  • 胎盤市場 - 歐洲
    • 歐洲：按應用劃分的胎盤市場，2019-2032 年
    • 歐洲：胎盤市場，按類型，2019-2032 年
    • 胎盤市場 - 英國
    • 胎盤市場 - 法國
    • 胎盤市場 - 德國
    • 胎盤市場 - 意大利
    • 胎盤市場 - 西班牙
    • 胎盤市場 - 荷蘭
    • 胎盤市場 - 俄羅斯
  • 胎盤市場 - 亞太地區
    • 亞太地區：按應用劃分的胎盤市場，2019-2032 年
    • 亞太地區：胎盤市場，按類型，2019-2032 年
    • 胎盤市場 - 中國
    • 胎盤市場 - 印度
    • 胎盤市場 - 馬來西亞
    • 胎盤市場 - 日本
    • 胎盤市場 - 印度尼西亞
    • 胎盤市場 - 韓國
  • 胎盤市場 - 中東和非洲
    • 中東和非洲：按應用劃分的胎盤市場，2019-2032 年
    • 中東和非洲：胎盤市場，按類型，2019-2032 年
    • 胎盤市場 - 沙特阿拉伯
    • 胎盤市場 - 阿拉伯聯合酋長國
    • 胎盤市場 - 以色列
    • 胎盤市場 - 南非
  • 胎盤市場 - 拉丁美洲
    • 拉丁美洲：按應用劃分的胎盤市場，2019-2032 年
    • 拉丁美洲：按類型劃分的胎盤市場，2019-2032 年
    • 胎盤市場 - 墨西哥
    • 胎盤市場 - 巴西
    • 胎盤市場 - 阿根廷

第 8 章競爭格局

  • 擴張和收購分析
    • 擴展名
    • 收購
  • 夥伴關係/協作/協議/披露

第 9 章公司簡介

  • Japan Natural Laboratories Co.Ltd
  • Japan Bio Products Co.Ltd
  • BIOON
  • CJT
  • Brroklyn Placenta Services
  • Atlanta Placenta
  • MiMedx Group, Inc
  • TelaGen
  • Thimba Li
  • Agri-Labco-Products
Product Code: PM3162

The global placenta market size is expected to reach USD 236.01 Million by 2032, according to a new study by Polaris market research. The report "Placenta Market Share, Size, Trends, Industry Analysis Report, By Type (Porcine, Equine, Ovine, Others); By Application; By Region; Segment Forecast, 2023-2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

One of the main factors driving the placenta market is the increase in demand for skin-rejuvenating and anti-aging products. For more than a century, wound care and wound healing have been aided by the utilization of the abundant stem cells found in the placenta. A potent combination of growth factors and anti-inflammatory proteins, in particular, found in the amniotic membrane, can help the body interact with cells when it is ill or injured.

The normal function of placenta cells can be restored with the aid of regenerative drugs. Effective treatments for chronic illnesses are projected to be made possible by the field's quick improvements. For instance, mesenchymal stem cells generated from human placentas are a new alternative source of MSCs with a number of benefits, according to a research article by Yifeng Lin published in 2022. In order to further understand their therapeutic effectiveness and potential underlying mechanisms, we infused HP-MSCs with cross-linked hyaluronic acid hydrogel to optimize their retention inside the uterus.

One of the key drivers of market expansion is significant R&D investments. In addition, the growing need for potent treatments to lessen the burden of disease during the predicted period is another factor fueling the growth. For instance, a 2022 research study by Felor Biniazan examined the effects of the placenta based amniotic epithelial cells on wound healing process & TGF induced scar formation in a murine injury model.

For instance, according to a research study by Kirat Chand that was published in 2022, hPD-MSC therapy causes changes in metabolite and protein levels as well as serum biomarker(s) of ageing and/or rejuvenation. Surprisingly, hPD-MSC treatment boosted serotonin synthesis due to faster rates of vitamin B6 metabolism. The expression of mRNAs and proteins linked to hepatocyte proliferation and mitochondrial biogenesis was changed by elevated liver serotonin levels following repeated injection therapy. After receiving hPD-MSC therapy, metabolite changes in the blood can be used to find ageing and/or rejuvenation biomarkers. Serotonin is also an important therapeutic target for correcting liver deterioration brought on by ageing.

Placenta Market Report Highlights

  • In 2022, the Ovine dominated the whole market, accounting for major sales revenue. The rising demand for dietary supplements, medicines, and cosmetics that contain placenta extracts is to blame for the market's expansion.
  • The pharmaceutical industry dominated the market, in 2022. The significant factors driving the market are an increase in clinical trials, an increase in strategic initiatives, an increase in the prevalence of chronic diseases, and improvements in healthcare services.
  • North America hold the largest revenue in 2022. The main factors driving the market include North America's robust biotechnology sector, the existence of major players, considerable R&D, and the promotion of personalized medications.
  • The global players with global presence include Brroklyn Placenta Services, Atlanta Placenta, MiMedx Group, TelaGen, Thimba Li, and Agri-Labco-Products.

Polaris Market Research has segmented the Placenta Market report based on product type, application, and region:

Placenta, Type Outlook (Revenue - USD Million, 2019 - 2032)

  • Porcine
  • Equine
  • Ovine
  • Others

Placenta, Application Outlook (Revenue - USD Million, 2019 - 2032)

  • Pharmaceuticals
  • Cosmetics
  • Supplements
  • Others

Placenta, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Placenta Market Insights

  • 4.1. Placenta Market - Industry Snapshot
  • 4.2. Placenta Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing use of renewable energy sources for energy production
      • 4.2.1.2. Rising fuel cell demand
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High cost production
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Placenta Industry trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Placenta Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Placenta, by Type, 2019-2032 (USD Million)
  • 5.3. Porcine
    • 5.3.1. Global Placenta Market, by Porcine, by Region, 2019-2032 (USD Million)
  • 5.4. Equine
    • 5.4.1. Global Placenta Market, by Equine, by Region, 2019-2032 (USD Million)
  • 5.5. Ovine
    • 5.5.1. Global Placenta Market, by Ovine, by Region, 2019-2032 (USD Million)
  • 5.6. Others
    • 5.6.1. Global Placenta Market, by Others, by Region, 2019-2032 (USD Million)

6. Global Placenta Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Placenta Market, by Application, 2019-2032 (USD Million)
  • 6.3. Pharmaceuticals
    • 6.3.1. Global Placenta Market, by Pharmaceuticals, by Region, 2019-2032 (USD Million)
  • 6.4. Cosmetics
    • 6.4.1. Global Placenta Market, by Cosmetics, by Region, 2019-2032 (USD Million)
  • 6.5. Supplements
    • 6.5.1. Global Placenta Market, by Supplements, by Region, 2019-2032 (USD Million)
  • 6.6. Others
    • 6.6.1. Global Placenta Market, by Others, by Region, 2019-2032 (USD Million)

7. Global Placenta Market, by Geography

  • 7.1. Key findings
  • 7.2. Introduction
    • 7.2.1. Placenta Market Assessment, By Geography, 2019-2032 (USD Million)
  • 7.3. Placenta Market - North America
    • 7.3.1. North America: Placenta Market, by Application, 2019-2032 (USD Million)
    • 7.3.2. North America: Placenta Market, by Type, 2019-2032 (USD Million)
    • 7.3.3. Placenta Market - U.S.
      • 7.3.3.1. U.S.: Placenta Market, by Application, 2019-2032 (USD Million)
      • 7.3.3.2. U.S.: Placenta Market, by Type, 2019-2032 (USD Million)
    • 7.3.4. Placenta Market - Canada
      • 7.3.4.1. Canada: Placenta Market, by Application, 2019-2032 (USD Million)
      • 7.3.4.2. Canada: Placenta Market, by Type, 2019-2032 (USD Million)
  • 7.4. Placenta Market - Europe
    • 7.4.1. Europe: Placenta Market, by Application, 2019-2032 (USD Million)
    • 7.4.2. Europe: Placenta Market, by Type, 2019-2032 (USD Million)
    • 7.4.3. Placenta Market - UK
      • 7.4.3.1. UK: Placenta Market, by Application, 2019-2032 (USD Million)
      • 7.4.3.2. UK: Placenta Market, by Type, 2019-2032 (USD Million)
    • 7.4.4. Placenta Market - France
      • 7.4.4.1. France: Placenta Market, by Application, 2019-2032 (USD Million)
      • 7.4.4.2. France: Placenta Market, by Type, 2019-2032 (USD Million)
    • 7.4.5. Placenta Market - Germany
      • 7.4.5.1. Germany: Placenta Market, by Application, 2019-2032 (USD Million)
      • 7.4.5.2. Germany: Placenta Market, by Type, 2019-2032 (USD Million)
    • 7.4.6. Placenta Market - Italy
      • 7.4.6.1. Italy: Placenta Market, by Application, 2019-2032 (USD Million)
      • 7.4.6.2. Italy: Placenta Market, by Type, 2019-2032 (USD Million)
    • 7.4.7. Placenta Market - Spain
      • 7.4.7.1. Spain: Placenta Market, by Application, 2019-2032 (USD Million)
      • 7.4.7.2. Spain: Placenta Market, by Type, 2019-2032 (USD Million)
    • 7.4.8. Placenta Market - Netherlands
      • 7.4.8.1. Netherlands: Placenta Market, by Application, 2019-2032 (USD Million)
      • 7.4.8.2. Netherlands: Placenta Market, by Type, 2019-2032 (USD Million)
    • 7.4.9. Placenta Market - Russia
      • 7.4.9.1. Russia: Placenta Market, by Application, 2019-2032 (USD Million)
      • 7.4.9.2. Russia: Placenta Market, by Type, 2019-2032 (USD Million)
  • 7.5. Placenta Market - Asia Pacific
    • 7.5.1. Asia Pacific: Placenta Market, by Application, 2019-2032 (USD Million)
    • 7.5.2. Asia Pacific: Placenta Market, by Type, 2019-2032 (USD Million)
    • 7.5.3. Placenta Market - China
      • 7.5.3.1. China: Placenta Market, by Application, 2019-2032 (USD Million)
      • 7.5.3.2. China: Placenta Market, by Type, 2019-2032 (USD Million)
    • 7.5.4. Placenta Market - India
      • 7.5.4.1. India: Placenta Market, by Application, 2019-2032 (USD Million)
      • 7.5.4.2. India: Placenta Market, by Type, 2019-2032 (USD Million)
    • 7.5.5. Placenta Market - Malaysia
      • 7.5.5.1. Malaysia: Placenta Market, by Application, 2019-2032 (USD Million)
      • 7.5.5.2. Malaysia: Placenta Market, by Type, 2019-2032 (USD Million)
    • 7.5.6. Placenta Market - Japan
      • 7.5.6.1. Japan: Placenta Market, by Application, 2019-2032 (USD Million)
      • 7.5.6.2. Japan: Placenta Market, by Type, 2019-2032 (USD Million)
    • 7.5.7. Placenta Market - Indonesia
      • 7.5.7.1. Indonesia: Placenta Market, by Application, 2019-2032 (USD Million)
      • 7.5.7.2. Indonesia: Placenta Market, by Type, 2019-2032 (USD Million)
    • 7.5.8. Placenta Market - South Korea
      • 7.5.8.1. South Korea: Placenta Market, by Application, 2019-2032 (USD Million)
      • 7.5.8.2. South Korea: Placenta Market, by Type, 2019-2032 (USD Million)
  • 7.6. Placenta Market - Middle East & Africa
    • 7.6.1. Middle East & Africa: Placenta Market, by Application, 2019-2032 (USD Million)
    • 7.6.2. Middle East & Africa: Placenta Market, by Type, 2019-2032 (USD Million)
    • 7.6.3. Placenta Market - Saudi Arabia
      • 7.6.3.1. Saudi Arabia: Placenta Market, by Application, 2019-2032 (USD Million)
      • 7.6.3.2. Saudi Arabia: Placenta Market, by Type, 2019-2032 (USD Million)
    • 7.6.4. Placenta Market - UAE
      • 7.6.4.1. UAE: Placenta Market, by Application, 2019-2032 (USD Million)
      • 7.6.4.2. UAE: Placenta Market, by Type, 2019-2032 (USD Million)
    • 7.6.5. Placenta Market - Israel
      • 7.6.5.1. Israel: Placenta Market, by Application, 2019-2032 (USD Million)
      • 7.6.5.2. Israel: Placenta Market, by Type, 2019-2032 (USD Million)
    • 7.6.6. Placenta Market - South Africa
      • 7.6.6.1. South Africa: Placenta Market, by Application, 2019-2032 (USD Million)
      • 7.6.6.2. South Africa: Placenta Market, by Type, 2019-2032 (USD Million)
  • 7.7. Placenta Market - Latin America
    • 7.7.1. Latin America: Placenta Market, by Application, 2019-2032 (USD Million)
    • 7.7.2. Latin America: Placenta Market, by Type, 2019-2032 (USD Million)
    • 7.7.3. Placenta Market - Mexico
      • 7.7.3.1. Mexico: Placenta Market, by Application, 2019-2032 (USD Million)
      • 7.7.3.2. Mexico: Placenta Market, by Type, 2019-2032 (USD Million)
    • 7.7.4. Placenta Market - Brazil
      • 7.7.4.1. Brazil: Placenta Market, by Application, 2019-2032 (USD Million)
      • 7.7.4.2. Brazil: Placenta Market, by Type, 2019-2032 (USD Million)
    • 7.7.5. Placenta Market - Argentina
      • 7.7.5.1. Argentina: Placenta Market, by Application, 2019-2032 (USD Million)
      • 7.7.5.2. Argentina: Placenta Market, by Type, 2019-2032 (USD Million)

8. Competitive Landscape

  • 8.1. Expansion and Acquisition Analysis
    • 8.1.1. Expansion
    • 8.1.2. Acquisitions
  • 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

  • 9.1. Japan Natural Laboratories Co.Ltd
    • 9.1.1. Company Overview
    • 9.1.2. Financial PerTypeance
    • 9.1.3. Type Benchmarking
    • 9.1.4. Recent Development
  • 9.2. Japan Bio Products Co.Ltd
    • 9.2.1. Company Overview
    • 9.2.2. Financial PerTypeance
    • 9.2.3. Type Benchmarking
    • 9.2.4. Recent Development
  • 9.3. BIOON
    • 9.3.1. Company Overview
    • 9.3.2. Financial PerTypeance
    • 9.3.3. Type Benchmarking
    • 9.3.4. Recent Development
  • 9.4. CJT
    • 9.4.1. Company Overview
    • 9.4.2. Financial PerTypeance
    • 9.4.3. Type Benchmarking
    • 9.4.4. Recent Development
  • 9.5. Brroklyn Placenta Services
    • 9.5.1. Company Overview
    • 9.5.2. Financial PerTypeance
    • 9.5.3. Type Benchmarking
    • 9.5.4. Recent Development
  • 9.6. Atlanta Placenta
    • 9.6.1. Company Overview
    • 9.6.2. Financial PerTypeance
    • 9.6.3. Type Benchmarking
    • 9.6.4. Recent Development
  • 9.7. MiMedx Group, Inc
    • 9.7.1. Company Overview
    • 9.7.2. Financial PerTypeance
    • 9.7.3. Type Benchmarking
    • 9.7.4. Recent Development
  • 9.8. TelaGen
    • 9.8.1. Company Overview
    • 9.8.2. Financial PerTypeance
    • 9.8.3. Type Benchmarking
    • 9.8.4. Recent Development
  • 9.9. Thimba Li
    • 9.9.1. Company Overview
    • 9.9.2. Financial PerTypeance
    • 9.9.3. Type Benchmarking
    • 9.9.4. Recent Development
  • 9.10. Agri-Labco-Products
    • 9.10.1. Company Overview
    • 9.10.2. Financial PerTypeance
    • 9.10.3. Type Benchmarking
    • 9.10.4. Recent Development

List of Tables

  • Table 1 Global Placenta Market, by Application, 2019-2032 (USD Million)
  • Table 2 Global Placenta Market, by Type, 2019-2032 (USD Million)
  • Table 3 Placenta Market Assessment, By Geography, 2019-2032 (USD Million)
  • Table 4 North America: Placenta Market, by Application, 2019-2032 (USD Million)
  • Table 5 North America: Placenta Market, by Type, 2019-2032 (USD Million)
  • Table 6 U.S.: Placenta Market, by Application, 2019-2032 (USD Million)
  • Table 7 U.S.: Placenta Market, by Type, 2019-2032 (USD Million)
  • Table 8 Canada: Placenta Market, by Application, 2019-2032 (USD Million)
  • Table 9 Canada: Placenta Market, by Type, 2019-2032 (USD Million)
  • Table 10 Europe: Placenta Market, by Application, 2019-2032 (USD Million)
  • Table 11 Europe: Placenta Market, by Type, 2019-2032 (USD Million)
  • Table 12 UK: Placenta Market, by Application, 2019-2032 (USD Million)
  • Table 13 UK: Placenta Market, by Type, 2019-2032 (USD Million)
  • Table 14 France: Placenta Market, by Application, 2019-2032 (USD Million)
  • Table 15 France: Placenta Market, by Type, 2019-2032 (USD Million)
  • Table 16 Germany: Placenta Market, by Application, 2019-2032 (USD Million)
  • Table 17 Germany: Placenta Market, by Type, 2019-2032 (USD Million)
  • Table 18 Italy: Placenta Market, by Application, 2019-2032 (USD Million)
  • Table 19 Italy: Placenta Market, by Type, 2019-2032 (USD Million)
  • Table 20 Spain: Placenta Market, by Application, 2019-2032 (USD Million)
  • Table 21 Spain: Placenta Market, by Type, 2019-2032 (USD Million)
  • Table 22 Netherlands: Placenta Market, by Application, 2019-2032 (USD Million)
  • Table 23 Netherlands: Placenta Market, by Type, 2019-2032 (USD Million)
  • Table 24 Russia: Placenta Market, by Application, 2019-2032 (USD Million)
  • Table 25 Russia: Placenta Market, by Type, 2019-2032 (USD Million)
  • Table 26 Asia Pacific: Placenta Market, by Application, 2019-2032 (USD Million)
  • Table 27 Asia Pacific: Placenta Market, by Type, 2019-2032 (USD Million)
  • Table 28 China: Placenta Market, by Application, 2019-2032 (USD Million)
  • Table 29 China: Placenta Market, by Type, 2019-2032 (USD Million)
  • Table 30 India: Placenta Market, by Application, 2019-2032 (USD Million)
  • Table 31 India: Placenta Market, by Type, 2019-2032 (USD Million)
  • Table 32 Malaysia: Placenta Market, by Application, 2019-2032 (USD Million)
  • Table 33 Malaysia: Placenta Market, by Type, 2019-2032 (USD Million)
  • Table 34 Japan: Placenta Market, by Application, 2019-2032 (USD Million)
  • Table 35 Japan: Placenta Market, by Type, 2019-2032 (USD Million)
  • Table 36 Indonesia: Placenta Market, by Application, 2019-2032 (USD Million)
  • Table 37 Indonesia: Placenta Market, by Type, 2019-2032 (USD Million)
  • Table 38 South Korea: Placenta Market, by Application, 2019-2032 (USD Million)
  • Table 39 South Korea: Placenta Market, by Type, 2019-2032 (USD Million)
  • Table 40 Middle East & Africa: Placenta Market, by Application, 2019-2032 (USD Million)
  • Table 41 Middle East & Africa: Placenta Market, by Type, 2019-2032 (USD Million)
  • Table 42 Saudi Arabia: Placenta Market, by Application, 2019-2032 (USD Million)
  • Table 43 Saudi Arabia: Placenta Market, by Type, 2019-2032 (USD Million)
  • Table 44 UAE: Placenta Market, by Application, 2019-2032 (USD Million)
  • Table 45 UAE: Placenta Market, by Type, 2019-2032 (USD Million)
  • Table 46 Israel: Placenta Market, by Application, 2019-2032 (USD Million)
  • Table 47 Israel: Placenta Market, by Type, 2019-2032 (USD Million)
  • Table 48 South Africa: Placenta Market, by Application, 2019-2032 (USD Million)
  • Table 49 South Africa: Placenta Market, by Type, 2019-2032 (USD Million)
  • Table 50 Latin America: Placenta Market, by Application, 2019-2032 (USD Million)
  • Table 51 Latin America: Placenta Market, by Type, 2019-2032 (USD Million)
  • Table 52 Mexico: Placenta Market, by Application, 2019-2032 (USD Million)
  • Table 53 Mexico: Placenta Market, by Type, 2019-2032 (USD Million)
  • Table 54 Brazil: Placenta Market, by Application, 2019-2032 (USD Million)
  • Table 55 Brazil: Placenta Market, by Type, 2019-2032 (USD Million)
  • Table 56 Argentina: Placenta Market, by Application, 2019-2032 (USD Million)
  • Table 57 Argentina: Placenta Market, by Type, 2019-2032 (USD Million)

List of Figures

  • Figure 1 Global Placenta Market, 2019-2032 (USD Million)
  • Figure 2 Integrated Ecosystem
  • Figure 3 Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4 Market by Geography
  • Figure 5 Porter's Five Forces
  • Figure 6 Market by Application
  • Figure 7 Global Placenta Market, by Application, 2022 & 2032 (USD Million)
  • Figure 8 Market by Type
  • Figure 9 Global Placenta Market, by Type, 2022 & 2032 (USD Million)
  • Figure 10 Placenta Market Assessment, By Geography, 2019-2032 (USD Million)
  • Figure 11 Strategic Analysis - Placenta Market